Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Gynecol Oncol. 2016 Aug 12;143(2):302–306. doi: 10.1016/j.ygyno.2016.08.236

Table 1.

Demographic and clinicopathologic information.

Demographic and clinical information (n = 30)
Median age, years (range) 42.5 (28–77)
Median BMI, kg/m2 (range) 26.5 (18.9–52)
N (%)
Clinical stage 3 (10.0)
 ≤IA2 25 (83.3)
 IB1 2 (6.7)
 IB2
Procedure
 RA-RH or MRH 26 (86.7)
 Cold knife cone 1 (3.3)
 Aborted RA-RH or RA-MRH 3 (10.0)
Location of procedure
 Johns Hopkins Hospital 18 (60.0)
 Texas Oncology 12 (40.0)
History of conization prior to procedure 16 (55.7)
Median clinical tumor size, cm (range) 2.0 (0–4.0)
 Microscopic 7 (23.3)
 <1 cm 3 (10.0)
 ≥1 & <2 cm 3 (10.0)
 ≥2 & <3 cm 7 (23.3)
 ≥3 & <4 cm 6 (20.0)
 ≥4 cm 4 (13.3)
Pathologic and surgical information

Median pathologic size, cm (range) 2.1 (0.1–4.5)
Histology
 Squamous cell carcinoma 20 (66.7)
 Adenocarcinoma 7 (23.3)
 Adenosquamous carcinoma 3 (10.0)
Gradea
 Well differentiated 5 (17.9)
 Moderately differentiated 15 (53.6)
 Poorly differentiated 8 (28.6)
Lymphovascular space invasion presentb 9 (33.3)
Ultrastaging performed 13 (43.3)
Median (mean) number of SLN retrieved per hemipelvis (range) 2 (2.4) (0–11)
Median (mean) number of non-SLN pelvic nodes per hemi-pelvis (range) 7 (6.5) (0–20)
Cases with evidence of lymphatic metastasis
 Frank metastasis 4 (13.3)
 Cytokeratin positive cells only 1 (3.3)

RA-RH = Robotic assisted radical hysterectomy.

MRH = modified radical hysterectomy.

a

Data on grade was not available for 2 patients.

b

Data on LVSI not available for 3 patients.